The rationale and design of the rule-study: Effectiveness of vascular screening program on risk factor reduction in patients at high risk for atherosclerosis

被引：0
|
作者：
Brouwer, B. G.
Algra, A.
van der Wall, E. E.
Romjin, J. A.
van Bockel, J. H.
Bollen, E. L. E. M.
Visseren, F. L. J.
van der Graaf, Y.
机构：
[1] UMC, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
[2] UMC, Dept Neurol, Utrecht, Netherlands
[3] UMC, Sect Vasc Med, Utrecht, Netherlands
来源：
EUROPEAN JOURNAL OF EPIDEMIOLOGY | 2006年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：21 / 21
页数：1
相关论文
共 50 条
  • [1] The Atherosclerosis Risk in Young Adults (ARYA) study: Rationale and design
    A. Oren
    L.E. Vos
    C.S.P.M. Uiterwaal
    A.A.A. Bak
    W.H.W. Gorissen
    D.E. Grobbee
    M.L. Bots
    European Journal of Epidemiology, 2003, 18 (7) : 715 - 728
  • [2] The Atherosclerosis Risk in Young Adults (ARYA) study: Rationale and design
    Oren, A
    Vos, LE
    Uiterwaal, CSPM
    Bak, AAA
    Gorissen, WHW
    Grobbee, DE
    Bots, ML
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2003, 18 (07) : 715 - 727
  • [3] Rationale and design of a study to evaluate management of proteinuria in patients at high risk for vascular events: the IMPROVE trial
    Bakris, G. L.
    Ruilope, L.
    Locatelli, F.
    Ptaszynska, A.
    Pieske, B.
    Raz, I.
    Voors, A. A.
    Dechamplain, J.
    Weber, M. A.
    JOURNAL OF HUMAN HYPERTENSION, 2006, 20 (09) : 693 - 700
  • [4] Rationale and design of a study to evaluate management of proteinuria in patients at high risk for vascular events: the IMPROVE trial
    G L Bakris
    L Ruilope
    F Locatelli
    A Ptaszynska
    B Pieske
    I Raz
    A A Voors
    J Dechamplain
    M A Weber
    Journal of Human Hypertension, 2006, 20 : 693 - 700
  • [5] Effectiveness of a Risk Factor Based GBS Screening Program.
    Neil, Peter
    Holden, Jessica M.
    Saini, Rattan
    Giles, Michelle
    Wallace, Euan M.
    REPRODUCTIVE SCIENCES, 2014, 21 (03) : 262A - 262A
  • [6] STUDY OF THE EFFECTIVENESS OF A HEALTH-RISK REDUCTION PROGRAM
    SMITH, MF
    BENJAMINBOBROFF, L
    EVALUATION & THE HEALTH PROFESSIONS, 1991, 14 (01) : 88 - 99
  • [7] COSEHC global vascular risk management quality improvement program: rationale and design
    Ferrario, Carlos M.
    Moore, Michael A.
    Bestermann, William, Jr.
    Colby, Chris
    Exuzides, Alex
    Simmons, Debra
    Panjabi, Sumeet
    VASCULAR HEALTH AND RISK MANAGEMENT, 2010, 6 : 1135 - 1145
  • [8] EVIDENCE FOR ATHEROSCLEROSIS REGRESSION WITH RISK FACTOR REDUCTION IN HYPERLIPOPROTEINEMIC PATIENTS
    BLANKENHORN, DH
    BARNDT, R
    CRAWFORD, DW
    CLINICAL RESEARCH, 1976, 24 (03): : A471 - A471
  • [9] Lifetime Risk of Dementia by Midlife Vascular Risk Factor Burden: The Atherosclerosis Risk in Communities (ARIC) Study
    Hu, Jiaqi
    Fang, Michael
    Gottesman, Rebecca F.
    Lutsey, Pamela L.
    Mosley, Thomas
    Selvin, Elizabeth
    Coresh, Joe
    CIRCULATION, 2024, 149
  • [10] Benefit of a short atherosclerosis prevention program on post-stroke vascular risk reduction
    Kazadi, A.
    Sibon, I.
    Lafitte, M.
    Pucheu, Y.
    Renou, P.
    Rouanet, F.
    Couffinhal, T.
    REVUE NEUROLOGIQUE, 2013, 169 (04) : 314 - 320
12345